Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

Should all patients with Hodgkin lymphoma who relapse after autologous SCT be considered for allogeneic SCT?

Blood Adv (2018) 2 (7): 817–820.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals